Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Martin Hoebeke"'
Autor:
Corentin Deckers, Florian Bélik, Olivier Denis, Pierre Bogaerts, Isabel Montesinos, Catherine Berhin, Warda Bouchahrouf, Martin Hoebeke, Stephanie Evrard, Nicolas Gilliard, Merve Okur, Te-Din Huang
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract Background Aztreonam-avibactam (ATM-AVI) combination shows promising effectiveness on most carbapenemase-producing Gram-negatives, yet standardized antibiotic susceptibility testing (AST) methods for evaluating the combination in clinical la
Externí odkaz:
https://doaj.org/article/28279ad7a2304307bef472c1875ebe9d
Autor:
Youri Glupczynski, Anne-Marie Van den Abeele, Martin Hoebeke, Katelijne Floré, Ahalieyah Anantharajah, Julie Descy, K. Magerman, Olivier Denis, Philippe Declercq, Pierre Bogaerts, Hector Rodriguez-Villalobos, Te-Din Huang
Publikováno v:
European journal of clinical microbiology & infectious diseases, Vol. 40, no. 3, p. 575-579 (2021)
PURPOSE: Broth microdilution (BMD) stays as the reference testing method for determination of antimicrobial susceptibility testing (AST) to colistin and is considered essential for patient management and for monitoring of colistin resistance. This mu
Autor:
Pierre Bogaerts, Audrey Noël, Sami Yunus, Te-Din Huang, Catherine Berhin, Martin Hoebeke, Warda Bouchahrouf, Youri Glupczynski
Four screening assays aimed for rapid detection of carbapenemase production from Gram-negative bacterial isolates, i.e., the Neo-Rapid Carb kit (Rosco Diagnostica A/S), the Rapidec Carba NP test (bioMérieux SA), the β Carba test (Bio-Rad Laboratori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba2537306e2e7ac3012481f8de8afbb6
https://europepmc.org/articles/PMC5277521/
https://europepmc.org/articles/PMC5277521/
Autor:
Stéphanie Evrard, Pierre Bogaerts, Youri Glupczynski, Martin Hoebeke, Thierry Naas, Gaelle Cuzon
Publikováno v:
International journal of antimicrobial agents. 48(2)
The dissemination of Gram-negative bacteria (GNB) producing extended-spectrum β-lactamases (ESBLs), plasmid-encoded cephalosporinases (pAmpCs) and carbapenemases is a matter of great clinical concern. In this study, we evaluated a new low-density DN